Fol. Biol. 2023, 69, 163-172
https://doi.org/10.14712/fb2023069050163
MiR-19a-3p Promotes Aerobic Glycolysis in Ovarian Cancer Cells via IGFBP3/PI3K/AKT Pathway
References
1. 2019) The NF-κB-modulated miR-19a-3p enhances malignancy of human ovarian cancer cells through inhibition of IGFBP-3 expression. Mol. Carcinog. 58, 2254-2265.
< , R., Cui, Z., Ma, Y. et al. (https://doi.org/10.1002/mc.23113>
2. 2020) Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells. Int. J. Mol. Sci. 21, 5165.
< , M., Terenziani, R., Zoppi, S. et al. (https://doi.org/10.3390/ijms21145165>
3. 2022) FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis. Cell Death Dis. 13, 765.
< , K., Chen, S., Zhu, C. et al. (https://doi.org/10.1038/s41419-022-05213-w>
4. 2019) Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma. J. Neurosurg. 132, 168-179.
< , C., Chen, P. Y., Lin, Y. Y. et al. (https://doi.org/10.3171/2018.8.JNS181217>
5. 2022) ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J. Exp. Clin. Cancer Res. 41, 15.
< , S., Liang, S., Cheng, Z. et al. (https://doi.org/10.1186/s13046-021-02229-6>
6. 2020) Vitamin K2 promotes PI3K/AKT/HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells. Sci. Rep. 1, 7714.
< , F., Mei, C., Yang, L. et al. (https://doi.org/10.1038/s41598-020-64880-x>
7. 2017) miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDH. Neoplasma 64, 244-252.
< , R. L., Wang, F. P., Zhang, P. A. et al. (https://doi.org/10.4149/neo_2017_211>
8. 2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
< , D., Weinberg, R. A. (https://doi.org/10.1016/j.cell.2011.02.013>
9. 2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531.
< , L., Hannon, G. J. (https://doi.org/10.1038/nrg1379>
10. 2021) miRNA interplay: mechanisms and consequences in cancer. Dis. Model. Mech. 14, 1-9.
< , M., Tran, N. (https://doi.org/10.1242/dmm.047662>
11. 2021) Cancer signaling drives cancer metabolism: AKT and the Warburg effect. Cancer Res. 81, 4896-4898.
< , A. M., Manning, B. D. (https://doi.org/10.1158/0008-5472.CAN-21-2647>
12. 2019) Clinical significance of serum IGFBP-3 in colorectal cancer. J. Clin. Lab. Anal. 33, e22912.
< , Y. L., Luo, P., Ji, G. Y. et al. (https://doi.org/10.1002/jcla.22912>
13. 2020) Insulin growth factor binding protein 7 (IGFBP7)-related cancer and IGFBP3 and IGFBP7 crosstalk. Front. Oncol. 10, 727.
< , L., Shen, F., Weinfeld, M. et al. (https://doi.org/10.3389/fonc.2020.00727>
14. 2009) Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr. Rev. 30, 417-437.
< , S., Feldman, D., Oh, Y. (https://doi.org/10.1210/er.2008-0028>
15. 2019a) Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis. Pathol. Res. Pract. 215, 152409.
< , H., Xu, H., Xing, R. et al. (https://doi.org/10.1016/j.prp.2019.04.001>
16. 2019b) PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation. Protein Cell 10, 583-594.
< , T., Han, J., Jia, L. et al. (https://doi.org/10.1007/s13238-019-0618-z>
17. 2019c) Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells. Gene 712, 143956.
< , Y., Xu, Q., Yang, W. et al. (https://doi.org/10.1016/j.gene.2019.143956>
18. 2020) Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis. J. Cell. Mol. Med. 24, 11883-11902.
< , L. H., Chou, H. C., Chang, S. J. et al. (https://doi.org/10.1111/jcmm.15808>
19. 2021) Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression. Cancer Lett. 518, 230-242.
< , S., Li, Y., Wang, D. et al. (https://doi.org/10.1016/j.canlet.2021.07.025>
20. 2019) miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells. Arch. Biochem. Biophys. 661, 1-9.
< , J., Wang, L., Chen, W. et al. (https://doi.org/10.1016/j.abb.2018.10.014>
21. 2021) The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis. Cell Death Dis. 12, 328.
< , X., Zheng, E., Wei, L. et al. (https://doi.org/10.1038/s41419-021-03596-w>
22. 2012) Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol. Oncol. 127, 75-82.
< , C., Walters, S. Butler, J. et al. (https://doi.org/10.1016/j.ygyno.2012.06.033>
23. 2020) TGF-β-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion. Mol. Oncol. 14, 2609-2628.
< , R., Tapia-Galisteo, A., Martín-García, L. et al. (https://doi.org/10.1002/1878-0261.12779>
24. 2020) Cancer metabolism: phenotype, signaling and therapeutic targets. Cells 9, 2308.
< , J. H., Pyun, W. Y., Park, H. W. (https://doi.org/10.3390/cells9102308>
25. 2019) S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma. EBioMedicine 40, 210-223.
< , Y., Zhao, S., Wang, S. et al. (https://doi.org/10.1016/j.ebiom.2018.12.038>
26. 2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209-249.
< , H., Ferlay, J., Siegel, R. L. et al. (https://doi.org/10.3322/caac.21660>
27. 2023) The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism. Int. J. Mol. Sci. 24, 2652.
< , L. Y., Smit, D. J., Jücker, M. (https://doi.org/10.3390/ijms24032652>
28. 2016) Cancer metabolism at a glance. J. Cell Sci. 129, 3367-3373.
< , A., Kamphorst, J. J., Markert, E. K. et al. (https://doi.org/10.1242/jcs.181016>
29. 2017) Aberrant SIRT6 expression contributes to melanoma growth: role of the autophagy paradox and IGF-AKT signaling. Autophagy 7, 1-16.
, L., Guo, W., Ma, J. et al. (
30. 2021) CPNE1 enhances colorectal cancer cell growth, glycolysis, and drug resistance through regulating the AKT-GLUT1/HK2 pathway. Onco Targets Ther. 14, 699-710.
< , Y., Pan, S., He, X. et al. (https://doi.org/10.2147/OTT.S284211>
31. 2013) Dual roles of PKM2 in cancer metabolism. Acta Biochim. Biophys. Sin. (Shanghai) 45, 27-35.
< , S., Le, H. (https://doi.org/10.1093/abbs/gms106>
32. 2016) MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway. Tumor Biol. 37, 14989-14997.
< , Z., Lichun, F., Na, X. et al. (https://doi.org/10.1007/s13277-016-5415-1>
33. 2019) Up-regulation of insulin-like growth factor binding protein-3 is associated with brain metastasis in lung adenocarcinoma. Mol. Cells 42, 321-332.
, L., Li, J., Fu, S. et al. (
34. 2022) Noncoding RNAs in the glycolysis of ovarian cancer. Front. Pharmacol. 13, 855488.
< , C., Liu, N. (https://doi.org/10.3389/fphar.2022.855488>
35. 2021) Role of hypoxia inducible factor-1 in cancer stem cells (review). Mol. Med. Rep. 23, 17.
, Q., Han, Z., Zhu, Y. et al. (